MTNB Stock Analysis: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$0.32
-0.16 (-33.23%)
▼
5d:
-48.38%
30d:
-60.5%
90d:
-36.28%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MTNB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MTNB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $0.32, which is considered oversold relative to its 30-day fair value range of $0.56 to $0.78.
Technical Outlook: Technically, MTNB is showing sideways momentum. The price is currently testing key support at $0.69. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 33.2% recently.
Market Sentiment: MTNB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+6150.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MTNB is showing sideways momentum. The price is currently testing key support at $0.69. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 33.2% recently.
Market Sentiment: MTNB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+6150.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.56 -
$0.78
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-33.2%)
- BULLISH: Trading 6150.0% below Wall St target ($30.00)
- CAUTION: 5-day price weakness (-48.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.56 -
$0.78
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.69
Resistance Level
$0.88
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$30.00
(+6150.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 14, 2026 11:53 AM ET
Data refreshes hourly during market hours. Next update: 12:53 PM
Data refreshes hourly during market hours. Next update: 12:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 49 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 54 HOLD |
|
XNCR
Xencor Inc |
STRONG BUY
12 analysts |
$28 | 61 BUY |
